DIGOXIN ACTIVATES SARCOPLASMIC-RETICULUM CA-2+-RELEASE CHANNELS - A POSSIBLE ROLE IN CARDIAC INOTROPY

1 The effect of digoxin on rapid Ca-45(2+) efflux from cardiac and skeletal sarcoplasmic reticulum (SR) vesicles was investigated. Additionally the interaction of digoxin with single cardiac and skeletal muscle SR Ca2+-release channels incorporated into planar phospholipid bilayers and held under voltage clamp was determined. 2 Digoxin (I nm) increased the initial rate and amount of Ca2+-induced release of Ca-45(2+) from cardiac SR vesicles, passively loaded with (CaCl2)-Ca-45, at an extravesicular [Ca2+] of 0.1 mum. The efflux in the presence and absence of digoxin was inhibited at pm extravesicular Ca2+ and blocked by 5 mm Mg2+. 3 To elucidate the mechanism of action of digoxin, single-channel recording was used. Digoxin (1-20 nm) increased single-channel open probability (P(o)) when added to the cytosolic but not the luminal face of the cardiac channel in the presence of sub-maximally activating Ca2+ (0.1 muM- 10 muM) with an EC50 of 0.91 nm at 10 mum Ca2+ . The mechanisms underlying the action of digoxin appear to be concentration-dependent. The activation observed at 1 nm digoxin appears to be consistent with the sensitization of the channel to the effects of Ca2+. At higher concentrations the drug appears to interact synergistically with Ca2+ to produce values of P(o) considerably greater than those seen with Ca2+ as the sole activating ligand. 4 Digoxin had no effect on single-channel conductance or the Ca2+/Tris permeability ratio. In channels activated by digoxin the P(o) was decreased by Mg2+. Single-channels were characteristically modified to a long lasting open, but reduced, conductance state when 100 nm ryanodine was added to the cytosolic side of the channel. 5 Activation of the cardiac SR Ca2+-release channel was observed with similar concentrations of digitoxin, however, higher concentrations of ouabain were required to increase P(o). In contrast, a steroid which is not positively inotropic, chlormadinone acetate, had no effect on either cardiac or skeletal SR Ca2+-release channel activity. 6 At concentrations up to 1 mum, digoxin had no effect on Ca2+-induced Ca-45(2+) efflux from skeletal muscle SR vesicles nor did it affect skeletal SR Ca2+-release channel P(o), reflecting a difference between the cardiac and skeletal isoforms of the Ca2+-release channel. 7 Since activation of the cardiac SR Ca2+-release channel occurs within the range of concentrations of digoxin encountered therapeutically, it is possible that activation of this channel contributes to the positive inotropic effect observed with this drug. Further, activation of the channel by higher concentrations of digoxin may contribute to the toxic effects seen clinically.